163 related articles for article (PubMed ID: 35723873)
1. Prevalence of monoclonal gammopathy of undetermined significance in US black women.
Bertrand KA; Zirpoli G; Niharika Pillalamarri B; Szalat R; Palmer JR; Kataria Y
Am J Hematol; 2022 Sep; 97(9):E341-E343. PubMed ID: 35723873
[No Abstract] [Full Text] [Related]
2. Monoclonal gammopathy of undetermined significance in medical hospital admissions - a new strategy for screening?
Turesson I
Br J Haematol; 2020 Jun; 189(6):1010-1011. PubMed ID: 32072614
[No Abstract] [Full Text] [Related]
3. [Epidemiology of monoclonal gammopathies].
Hurez D
Rev Prat; 1993 Feb; 43(3):271-4. PubMed ID: 8502953
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal gammopathy of uncertain significance.
Alejo E; Puertas B; Mateos MV
Med Clin (Barc); 2023 Sep; 161(5):217-224. PubMed ID: 37330390
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal Gammopathy of Undetermined Significance.
Gonsalves WI; Rajkumar SV
Ann Intern Med; 2022 Dec; 175(12):ITC177-ITC192. PubMed ID: 36508741
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of monoclonal gammopathies and clinical outcomes in a high-risk US population screened by mass spectrometry: a multicentre cohort study.
El-Khoury H; Lee DJ; Alberge JB; Redd R; Cea-Curry CJ; Perry J; Barr H; Murphy C; Sakrikar D; Barnidge D; Bustoros M; Leblebjian H; Cowan A; Davis MI; Amstutz J; Boehner CJ; Lightbody ED; Sklavenitis-Pistofidis R; Perkins MC; Harding S; Mo CC; Kapoor P; Mikhael J; Borrello IM; Fonseca R; Weiss ST; Karlson E; Trippa L; Rebbeck TR; Getz G; Marinac CR; Ghobrial IM
Lancet Haematol; 2022 May; 9(5):e340-e349. PubMed ID: 35344689
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
Kyle RA
Eur J Haematol Suppl; 1989; 51():70-5. PubMed ID: 2516809
[TBL] [Abstract][Full Text] [Related]
8. Does my patient with a serum monoclonal spike have multiple myeloma?
Bianchi G; Ghobrial IM
Hematol Oncol Clin North Am; 2012 Apr; 26(2):383-93, ix. PubMed ID: 22463833
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma Survival Among Hispanics Living in Puerto Rico.
Castañeda-Avila MA; Ramos TS; Torres-Cintrón CR; Gierbolini-Bermúdez A; Tortolero-Luna G; Ortiz-Ortiz KJ
J Registry Manag; 2023; 50(4):167-169. PubMed ID: 38504710
[No Abstract] [Full Text] [Related]
10. [Monoclonal gammopathy of undetermined significance and multiple myeloma].
Schmalzing M; Tony HP; Knop S
Z Rheumatol; 2017 Oct; 76(Suppl 2):33-37. PubMed ID: 29330758
[TBL] [Abstract][Full Text] [Related]
11. Autoimmunity, Infections, and the Risk of Monoclonal Gammopathy of Undetermined Significance.
Sigurbergsdóttir AÝ; Love TJ; Kristinsson SY
Front Immunol; 2022; 13():876271. PubMed ID: 35572590
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of Monoclonal Gammopathy of Undetermined Significance in Black South African Men.
Cicero KI; Joffe M; Patel M; Chiuzan C; Pentz A; Ruff P; Lentzsch S; Leng S; Jacobson JS; Rebbeck TR; Neugut AI
Cancer Epidemiol Biomarkers Prev; 2022 Dec; 31(12):2192-2198. PubMed ID: 36126958
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal gammopathy in atomic bomb survivors.
Neriishi K; Yoshimoto Y; Carter RL; Matsuo T; Ichimaru M; Mikami M; Abe T; Fujimura K; Kuramoto A
Radiat Res; 1993 Mar; 133(3):351-9. PubMed ID: 8451386
[TBL] [Abstract][Full Text] [Related]
14. [Epidemiology of monoclonal gammopathy in a general hospital and a university internal medicine department].
Decaux O; Rodon P; Ruelland A; Estepa L; Leblay R; Grosbois B
Rev Med Interne; 2007 Oct; 28(10):670-6. PubMed ID: 17566610
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
Kyle RA; San-Miguel JF; Mateos MV; Rajkumar SV
Hematol Oncol Clin North Am; 2014 Oct; 28(5):775-90. PubMed ID: 25212882
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for severe infection and mortality in COVID-19 and monoclonal gammopathy of undetermined significance.
Ho M; Zanwar S; Buadi FK; Ailawadhi S; Larsen J; Bergsagel L; Binder M; Chanan-Khan A; Dingli D; Dispenzieri A; Fonseca R; Gertz MA; Gonsalves W; Go RS; Hayman S; Kapoor P; Kourelis T; Lacy MQ; Leung N; Lin Y; Muchtar E; Roy V; Sher T; Warsame R; Fonder A; Hobbs M; Hwa YL; Kyle RA; Rajkumar SV; Kumar S
Blood; 2022 Nov; 140(18):1997-2000. PubMed ID: 36096078
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal gammopathy in a tertiary referral hospital.
Tamimi W; Alaskar A; Alassiri M; Alsaeed W; Alarifi SA; Alenzi FQ; Jawdat D
Clin Biochem; 2010 Jun; 43(9):709-13. PubMed ID: 20206156
[TBL] [Abstract][Full Text] [Related]
18. Silicone gel implants and monoclonal gammopathies: three cases of multiple myeloma and the prevalence of multiple myeloma and monoclonal gammopathy of undetermined significance.
Silverman S; Vescio R; Silver D; Renner S; Weiner S; Berenson J
Curr Top Microbiol Immunol; 1996; 210():367-74. PubMed ID: 8565579
[No Abstract] [Full Text] [Related]
19. Secondary monoclonal gammopathy of undetermined significance after allogeneic stem cell transplantation in multiple myeloma.
Schmitz MF; Otten HG; Franssen LE; van Dorp S; Strooisma T; Lokhorst HM; van de Donk NW
Haematologica; 2014 Dec; 99(12):1846-53. PubMed ID: 25193963
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma.
Kyle RA; Rajkumar SV
JAMA Oncol; 2015 May; 1(2):174-5. PubMed ID: 26181018
[No Abstract] [Full Text] [Related]
[Next] [New Search]